Lung Disease Clinical Trials

A listing of Lung Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1499 clinical trials
A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19 (COVSurf)

Lung surfactant is present in the lungs. It covers the alveolar surface where it reduces the work of breathing and prevents the lungs from collapsing. In some respiratory diseases and in

mechanical ventilation
  • 0 views
  • 10 May, 2022
  • 2 locations
Rural Hospital-Level Care at Home for Acutely Ill Adults

This study examines the implications of providing hospital-level care in rural homes.

heart failure
COPD
diabetes
  • 0 views
  • 20 Apr, 2022
  • 1 location
Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities ((MARGARET))

Phase 1 and 2 trial to study the safety, pharmacokinetics, and efficacy of TAS0953/HM06 in patients with advanced solid tumors with RET gene abnormalities. Phase 1 aims to determine the Maximum Tolerated Dose (MTD) and identify the Recommended Phase 2 Dose (RP2D) to be used in phase 2.

  • 0 views
  • 05 May, 2022
  • 12 locations
Keynatinib in Treated Patients With NSCLC and Brain Metastases

The purpose of this study is to evaluate the safety and efficacy of Keynatinib capsules in patients with advanced non-small cell lung cancer (NSCLC) with brain metastasis or progression of brain

  • 0 views
  • 05 May, 2022
  • 3 locations
PhIb Study Evaluating Safety and Efficacy of Combination Osimertinib and Ipilimumab in Patients w EGFR Mutated NSCLC (Osi+Ipi)

This is a prospective, open label, interventional trial beginning with a phase 1b safety run-in followed by an expansion cohort.

  • 0 views
  • 01 May, 2022
  • 1 location
A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors

A phase I/II study to examine the safety, tolerability, pharmacokinetics and efficacy of XZP-5955 tablets in patients with advanced solid tumors harboring NTRK or ROS1 gene fusion

  • 0 views
  • 23 May, 2022
  • 1 location
Comparing Different Sizes of Small-bore Chest Drains in Malignant Pleural Effusion

Malignant pleural effusion (MPE) is a very common medical condition, especially among patients with disseminated cancers. Chest drain insertion aims to drain the pleural fluid collection and relieve dyspnea. Small bore chest tubes are recommended as the first line therapy for draining pleural effusions. However, there is no clinical data …

Accepts healthy volunteers
  • 0 views
  • 24 May, 2022
  • 1 location
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

This phase I trial studies the side effects and best dose of nivolumab when given with ipilimumab in treating patients with human immunodeficiency virus (HIV) associated classical Hodgkin lymphoma that has returned after a period of improvement or does not respond to treatment, or solid tumors that have spread to …

cancer chemotherapy
lymphoma
HIV Vaccine
hiv-1 infection
lipase
  • 226 views
  • 03 May, 2022
  • 23 locations
Personalized Exercise Therapy and Self-management Support for Patients With Multimorbidity (MOBILIZE)

Chronic conditions such as knee or hip osteoarthritis (OA), chronic obstructive pulmonary disease (COPD), heart failure (HF), coronary heart disease (CHD), hypertension, type 2 diabetes mellitus

depressed mood
hypertension
heart failure
heart disease
diabetes
  • 0 views
  • 27 May, 2022
  • 14 locations
Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers

Background Small cell lung cancer (SCLC) and high-grade neuroendocrine cancers (HGNEC) are aggressive neuroendocrine cancers. At first, SCLC and HGNEC respond to

cancer chemotherapy
kinase inhibitor
neutrophil count
measurable disease
ATR
  • 0 views
  • 24 May, 2022
  • 1 location